http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-282889-B6
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f4dce064add4f464596348bea6de4c5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
filingDate | 1992-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb076a4d749e325ccf9eaaeaa32990f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94993e3527690a59ffbca9de1fa85ac7 |
publicationDate | 1997-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CZ-282889-B6 |
titleOfInvention | The use of diphosphonates and parathyroid hormone for the manufacture of a medicament for use in the treatment of osteoporosis |
abstract | The present invention relates to the use of a diphosphonate for the manufacture of a medicament that is used to treat an osteoporosis regimen comprising a thirty day treatment period comprising administering a diphosphonate and a parathyroid hormone. The present invention further relates to a method for increasing the bone mass of a human and other animals affected by osteroporosis, comprising a thirty day treatment period comprising a parathyroid hormone regimen and a diphosphonate regimen, wherein: a) the parathyroid hormone administration regimen comprises parathyroid hormone administration in an amount of from about 4 IU / kg per day to about 15 IU / kg per day, wherein said parathyroid hormone is administered to said subject at least one day every seven days from a thirty day treatment period; about 0.0005 mgP / kg to about 1.0 mgP / kg per day, wherein said diphosphonate is administered to said subject for at least one day of each thirty day treatment period.nnŕ |
priorityDate | 1991-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1015.